Innovation and access to medicines for neglected populations: could a treaty address a broken pharmaceutical R&D system?

PLoS Med. 2012;9(5):e1001218. doi: 10.1371/journal.pmed.1001218. Epub 2012 May 15.

Abstract

As part of a cluster of articles leading up to the 2012 World Health Report and critically reflecting on the theme of “no health without research,” Suerie Moon and colleagues argue for a global health R&D treaty to improve innovation in new medicines and strengthening affordability, sustainable financing, efficiency in innovation, and equitable health-centered governance.

MeSH terms

  • Biomedical Research*
  • Drug Discovery*
  • Global Health
  • Health Services Accessibility*
  • Healthcare Disparities*
  • Humans
  • International Cooperation*
  • Neglected Diseases / drug therapy*
  • Pharmaceutical Preparations*

Substances

  • Pharmaceutical Preparations